COMMON STI571: A BUDGET-FRIENDLY OPTION?

The introduction of off-brand imatinib represents a notable chance for patients battling a certain type of cancer and other conditions. Original brand-name imatinib, commonly known as Gleevec, carries a considerable price cost, frequently making it accessibility for some individuals. Off-brand ve